<DOC>
	<DOCNO>NCT02719665</DOCNO>
	<brief_summary>The purpose study understand effect fish oil supplement ( contain part omega-3 fatty acid ) inflammation . The investigator aim identify dose fish oil supplement effective . The name fish oil supplement `` SPM Emulsion . ''</brief_summary>
	<brief_title>THE OMEGA-SPM-DOSE OMEGA-SPM-PAD : Specialized Pro-Resolving Mediators Patients With Peripheral Artery Disease</brief_title>
	<detailed_description>The OMEGA-SPM-DOSE trial OMEGA-SPM-PAD trial two part pilot study aim investigate effect novel formulation nutritional supplement contain highly concentrate n-3 PUFA metabolite ( SPM Emulsion ) metabolo-lipidomic profile healthy volunteer patient PAD . Ten healthy volunteer ten patient PAD participate Part 1a , `` OMEGA-SPM-DOSE Study '' . A follow-up , placebo control , prospective study best dose modality determine Phase 1a take place wider PAD population ( n=30 ) , Phase 1b - `` OMEGA-SPM-PAD Study '' . Specific measurement include target metabolo-lipidomic profiling , establish marker inflammation , functional monocyte macrophage assay . The propose study potential provide important new insight role nutritional intervention PAD .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Healthy Volunteers : Age 2080 PAD Patients : Mild claudication rest pain ( Rutherford 14 ) Resting exercise ABI &lt; 0.9 TBI &lt; 0.6 Age 40 PAD Patients healthy volunteer : Plan undergo surgical procedure PVI treatment PAD within one month Evidence active infection Hypersensitivity allergy fish seafood Already n3 PUFA equivalent Chronic liver disease , endstage renal disease ( CKD 5 ) , chronic inflammatory disorder Poorly control diabetes ( HbA1C &gt; 8 % ) BMI &lt; 20 &gt; 35 Recent major surgery illness within 30 day Use immunosuppressive medication steroid History organ transplantation Pregnancy , plan become pregnant , lactate Healthy Volunteers : hsCRP &gt; 2mg/L Regular aspirin use Regular nonsteroidal antiinflammatory drug use</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>